• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • The Hatter Cardiovascular Institute Horizon Meetings
    • The 19th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2022 – London
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2022
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2022
    • Multiple Sclerosis Nurses at the Limits 2022
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Professor Rodrigo Alonso

Rodrigo Alonso Karlezi was Born in Valparaiso, Chile in 1963. Obtained his medical degree from Universidad de Valparaíso, Chile, and obtained the Prize of the Chilean Medical Association and from the Faculty of Medicine of Universidad de Valparaíso. Specialist in Internal Medicine from the same University, approved and homologated the corresponding Spanish title. Obtained his PhD in Medicine and the Magister in Clinical Nutrition from Universidad Auntónoma de Madrid.

From 1997 until June 2014, he worked at the Lipid Clinic, Internal Medicine Department at Fundación Jiménez Díaz, Madrid, Spain. His current position is chief of Lipid Unit and the Familial Hypercholesterolemia Program at the Nutrition Department, Clínica Las Condes, Santiago de Chile. Also, he works for the Spanish Familial Hypercholesterolemia Foundation, and is member of its Scientific Committee. Coordinates the Spanish Follow-up Study of Families with Familial Hypercholesterolemia (SAFEHEART) and the Spanish Registry of Familial Hyperlipidemia. He has collaborated in the development and implementation of the Familial Hypercholesterolemia Detection Program in the regions of Castilla y León and Madrid. Trustee of the International Familial Hypercholesterolemia Foundation. Member of the executive committee for regional federation (America) from the International Atherosclerosis Society.

He was professor of medicine at the University of Valparaiso from 1992 to 1997. Co- Director of the “on-line course” in Familial Hypercholesterolemia from the Spanish FH Foundation. He has participated as professor in courses from the foundation for Heatlh Promotion, Barcelona, accredited by the Continuing Educational Commission from the Spanish National Health System.

Author and Co-author of many manuscripts published in national and international journals and has been invited as speaker in national and international congresses and symposia. His main research areas are related to genetic aspects of Familial hyperlipidemia, interaction between genetic and other factors and cardiovascular disease.

« Dr Milton Packer
Professor Licio Velloso »

The 19th Malvern Diabetic Foot Conference
Wednesday, 11 - Friday, 13 May 2022, Malvern, UK

Cell Therapy at the Limits 2022
Monday, 27 & Tuesday, 28 June 2022, London, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 16 & Saturday, 17 September 2022, London, UK

Multiple Sclerosis at the Limits
Monday, 19 & Tuesday, 20 September 2022, London, UK

Cardiology, Diabetes & Nephrology at the Limits Japan
Saturday 15th & Sunday 16th October 2022, Tokyo, Japan

Cardiology, Diabetes & Nephrology at the Limits Canada
Q3 2022, Toronto, Canada

Cardiology, Diabetes & Nephrology at the Limits Brazil
April & October 2022, Brazil

The Hatter Cardiovascular Institute Horizon GP Meeting
Wednesday, 9 November 2022
London, UK

The Hatter Cardiovascular Institute Horizon Meeting
Wednesday, 23 November 2022, London, UK

Cardiology, Diabetes & Nephrology at the Limits 2023
London,UK

  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2022 At the Limits Ltd.
This site uses cookies More info